You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》美麗田園醫療遞上市申請 傳集資最多3億美元
阿思達克 04-25 12:00
美麗田園醫療健康產業近日向聯交所提交上市申請,由摩根士丹利、海通國際及華泰國際擔任聯席保薦人。外電引述消息人士指,美麗田園目標集資約2億至3億美元,將於年內掛牌。 初步招股資料顯示,集團經營「美麗田園」、「貝黎詩」、「秀可兒醫美」及「研源醫療」4個品牌,主要提供日常面部及身體護理服務、能量儀器與注射服務及抗衰醫學服務,截至4月15日擁有176家直營門店及172家加盟店,去年直營店活躍會員超過7.73萬名,平均消費20,832元人民幣。 去年度集團收入達到17.8億元人民幣,按年升18.5%,純利則增長28.2%至1.93億元人民幣。根據規劃,集資所得將用於擴張及升級服務網絡、進行加盟店戰略併購、投資IT系統以及一般營運用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account